IHAM
Integral Health Asset Management Portfolio holdings
AUM
$1.07B
This Quarter Return
+13.69%
1 Year Return
+40.53%
3 Year Return
+328.04%
5 Year Return
+535.34%
10 Year Return
–
AUM
$849M
AUM Growth
+$849M
(-15%)
Cap. Flow
-$210M
Cap. Flow
% of AUM
-24.68%
Top 10 Holdings %
Top 10 Hldgs %
53.19%
Holding
100
New
29
Increased
13
Reduced
14
Closed
35
Top Buys
| 1 |
Inspire Medical Systems
INSP
|
$33.8M |
| 2 |
Medtronic
MDT
|
$27M |
| 3 |
Cooper Companies
COO
|
$12.1M |
| 4 |
Fresenius Medical Care
FMS
|
$9.59M |
| 5 |
Bristol-Myers Squibb
BMY
|
$9.05M |
Top Sells
| 1 |
Elevance Health
ELV
|
$43.3M |
| 2 |
Humana
HUM
|
$28M |
| 3 |
Universal Health Services
UHS
|
$24M |
| 4 |
Becton Dickinson
BDX
|
$17.5M |
| 5 |
Cigna
CI
|
$16.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Kura Oncology
KURA
$732M
| – | – |
-100,000
| Closed | -$2.06M |
|
77
Krystal Biotech
KRYS
$4.35B
| – | – |
-85,000
| Closed | -$15.6M |
|
78
Icon
ICLR
$14B
| – | – |
-45,000
| Closed | -$14.1M |
|
|
79
Humana
HUM
$37.5B
| – | – |
-75,000
| Closed | -$28M |
|
80
Hologic
HOLX
$14.7B
| – | – |
-50,000
| Closed | -$3.71M |
|
81
Globus Medical
GMED
$7.94B
| – | – |
-125,000
| Closed | -$8.56M |
|
82
Edgewise Therapeutics
EWTX
$1.54B
| – | – |
0
| – | – |
|
83
Edwards Lifesciences
EW
$47.7B
| – | – |
-150,000
| Closed | -$13.9M |
|
|
84
Elevance Health
ELV
$72.4B
| – | – |
-80,000
| Closed | -$43.3M |
|
85
Elanco Animal Health
ELAN
$8.62B
| – | – |
-450,000
| Closed | -$6.49M |
|
86
Editas Medicine
EDIT
$225M
| – | – |
-675,000
| Closed | -$3.15M |
|
87
Dyne Therapeutics
DYN
$1.92B
| – | – |
-100,000
| Closed | -$3.53M |
|
88
Denali Therapeutics
DNLI
$2.24B
| – | – |
-325,000
| Closed | -$7.55M |
|
89
Corbus Pharmaceuticals
CRBP
$121M
| – | – |
-100,000
| Closed | -$4.53M |
|
90
Celldex Therapeutics
CLDX
$1.57B
| – | – |
0
| – | – |
|
|
91
Cigna
CI
$80.2B
| – | – |
-50,000
| Closed | -$16.5M |
|
|
92
Becton Dickinson
BDX
$54.3B
| – | – |
-75,000
| Closed | -$17.5M |
|
93
Apogee Therapeutics
APGE
$2.27B
| – | – |
-80,000
| Closed | -$3.15M |
|
94
Amgen
AMGN
$153B
| – | – |
-40,000
| Closed | -$12.5M |
|
95
Ionis Pharmaceuticals
IONS
$9.64B
| – | – |
-250,000
| Closed | -$11.9M |
|
96
Intuitive Surgical
ISRG
$158B
| – | – |
-10,000
| Closed | -$4.45M |
|
97
Relay Therapeutics
RLAY
$709M
| – | – |
-750,000
| Closed | -$4.89M |
|
98
Roivant Sciences
ROIV
$8.6B
| – | – |
-400,000
| Closed | -$4.23M |
|
99
Surgery Partners
SGRY
$2.89B
| – | – |
-200,000
| Closed | -$4.76M |
|
100
Sanofi
SNY
$122B
| – | – |
-200,000
| Closed | -$9.7M |
|